Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
- PMID: 26301691
- DOI: 10.1038/nm.3927
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Abstract
The antibody response to influenza is primarily focused on the head region of the hemagglutinin (HA) glycoprotein, which in turn undergoes antigenic drift, thus necessitating annual updates of influenza vaccines. In contrast, the immunogenically subdominant stem region of HA is highly conserved and recognized by antibodies capable of binding multiple HA subtypes. Here we report the structure-based development of an H1 HA stem-only immunogen that confers heterosubtypic protection in mice and ferrets. Six iterative cycles of structure-based design (Gen1-Gen6) yielded successive H1 HA stabilized-stem (HA-SS) immunogens that lack the immunodominant head domain. Antigenic characterization, determination of two HA-SS crystal structures in complex with stem-specific monoclonal antibodies and cryo-electron microscopy analysis of HA-SS on ferritin nanoparticles (H1-SS-np) confirmed the preservation of key structural elements. Vaccination of mice and ferrets with H1-SS-np elicited broadly cross-reactive antibodies that completely protected mice and partially protected ferrets against lethal heterosubtypic H5N1 influenza virus challenge despite the absence of detectable H5N1 neutralizing activity in vitro. Passive transfer of immunoglobulin from H1-SS-np-immunized mice to naive mice conferred protection against H5N1 challenge, indicating that vaccine-elicited HA stem-specific antibodies can protect against diverse group 1 influenza strains.
Similar articles
-
Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.J Virol. 2016 Sep 12;90(19):8496-508. doi: 10.1128/JVI.00880-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27440889 Free PMC article.
-
Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes.Vaccine. 2020 Jan 22;38(4):815-821. doi: 10.1016/j.vaccine.2019.10.093. Epub 2019 Nov 15. Vaccine. 2020. PMID: 31735504
-
Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.mBio. 2019 Feb 26;10(1):e02810-18. doi: 10.1128/mBio.02810-18. mBio. 2019. PMID: 30808695 Free PMC article.
-
Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin.Vaccines (Basel). 2020 Jul 12;8(3):382. doi: 10.3390/vaccines8030382. Vaccines (Basel). 2020. PMID: 32664628 Free PMC article. Review.
-
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.Vaccines (Basel). 2018 May 25;6(2):31. doi: 10.3390/vaccines6020031. Vaccines (Basel). 2018. PMID: 29799445 Free PMC article. Review.
Cited by
-
Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.J Virol. 2016 Sep 12;90(19):8496-508. doi: 10.1128/JVI.00880-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27440889 Free PMC article.
-
Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.Cell Syst. 2020 Dec 16;11(6):573-588.e9. doi: 10.1016/j.cels.2020.09.005. Epub 2020 Oct 7. Cell Syst. 2020. PMID: 33031741 Free PMC article.
-
Nanovaccines Displaying the Influenza Virus Hemagglutinin in an Inverted Orientation Elicit an Enhanced Stalk-Directed Antibody Response.Adv Healthc Mater. 2023 May;12(13):e2202729. doi: 10.1002/adhm.202202729. Epub 2023 Feb 3. Adv Healthc Mater. 2023. PMID: 36689343 Free PMC article.
-
Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses.Front Immunol. 2023 Feb 17;14:1086297. doi: 10.3389/fimmu.2023.1086297. eCollection 2023. Front Immunol. 2023. PMID: 36875062 Free PMC article. Review.
-
VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design.Curr Opin Virol. 2019 Feb;34:149-159. doi: 10.1016/j.coviro.2019.02.004. Epub 2019 Mar 16. Curr Opin Virol. 2019. PMID: 30884330 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous